Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094300 · ClinicalTrials.gov registry record · NA
Zenith® Dissection Endovascular System
A NA study, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02094300 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 26 participants.
The verdict
NCT02094300, a NA study, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of patients with aortic dissection.
Interventions
- DEVICE Zenith® Dissection Endovascular Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2007-12 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02094300
The ClinicalTrials.gov registry entry for NCT02094300 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zenith® Dissection Endovascular Graft is the first listed.
NCT02094300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02094300 about?
NCT02094300 is a clinical study titled "Zenith® Dissection Endovascular System". The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of patients with aortic dissection.
What is the current status of trial NCT02094300?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2007-12. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02094300?
The interventions under investigation include: Zenith® Dissection Endovascular Graft (DEVICE).
Who is sponsoring clinical trial NCT02094300?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.